Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
eli lilly
fremanezumab
indiana blog main
indiana top stories
life sciences
migraine
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
teva pharmaceutical
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
adalimumab (humira)
aducanumab
aduro biotech
affordable care act
alder biopharmaceutical
alez azar
allergan
What
approval
2
×
companies
2
×
drug
2
×
new
arguments
big
bio
biogen’s
biopharmaceutical
class
commercialized
competitors
convo
decades
drugs
earlier
failures
fda
littered
make
meeting
migraine
nash
neuro
news
oral
potential
price
remains
road
roundup
strategy
talk
therapies
won
year
Language
Current search:
drug
×
biotech
×
approval
×
companies
×
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More